- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Small Cap Stocks to Watch - DNDN, CECE, SWIM, OSTK, UNRG.
0 Comments | M2 Presswire, January, 2008
M2 PRESSWIRE-15 January 2008-SmallCapReview.com: Small Cap Stocks to Watch - DNDN, CECE, SWIM, OSTK, UNRG(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:15012008
Dendreon Corporation (Nasdaq: DNDN) Closed at $6.46. Today announced that the company has been granted a broad European patent covering the company's lead product candidate PROVENGE (sipuleucel-T), the Company's investigational active cellular immunotherapy for the treatment of advanced prostate cancer. European patent No. 0 870 022 B1 covers the composition of matter of PROVENGE as well as the company's other active cellular immunotherapy (ACI) product candidates, such as NEUVENGE(TM) (lapuleucel-T), which utilize Dendreon's Antigen Delivery Cassette(TM) technology. The patent also covers methods...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- SAS #82: sword or shield?
- Personality and organizational citizenship behavior
- Fighting financial reporting fraud
- The Middle Management Challenge: Moving From Crisis to Empowerment. - book reviews
- HR is mission critical at the FBI: thirty years of corporate HR experience helps the FBI's new HR chief revamp an organization that is changing to meet the challenges of the post-Sept. 11